Target Name: ERVFRD-1
NCBI ID: G405754
Review Report on ERVFRD-1 Target / Biomarker Content of Review Report on ERVFRD-1 Target / Biomarker
ERVFRD-1
Other Name(s): HERV-FRD provirus ancestral Env polyprotein | HERV-FRD | SYCY2_HUMAN | SU | Syncytin-2 | Envelope polyprotein | ERVFRDE1 | envFRD | endogenous retrovirus group FRD, member 1 | Surface protein | TM | endogenous retrovirus group FRD member 1 | GLLL6191 | UNQ6191 | syncytin 2 | HERV-FRD_6p24.1 provirus ancestral Env polyprotein | Transmembrane protein | envelope polyprotein | Endogenous retrovirus group FRD member 1, envelope | Endogenous retrovirus group FRD member 1 | HERV-W/FRD | endogenous retrovirus group FRD member 1, envelope

ERVFRD-1: Unlocking The Potential of Env Virus Research

ERVFRD-1 (HERV-FRD provirus ancestral Env polyprotein) is a protein that is found in the Env virus family, which is a group of enveloped viruses that include viruses such as HIV, HTLV, and VZV. Env viruses are known for their ability to infect a wide range of cell types and for their role in the development of various diseases, including cancer.

One of the unique features of ERVFRD-1 is its structure. It is a polyprotein that is composed of four distinct subunits that are arranged in a specific order. The four subunits of ERVFRD-1 are known as the Env-encoded proteins EAPI1, EAPI2 , EAPI3, and EAPI4. These proteins are involved in a wide range of functions in the Env virus, including the replication of the virus, the immune response, and the development of host cell toxicity.

One of the key functions of ERVFRD-1 is its ability to infect and replicate in a wide range of cell types. This makes it an attractive drug target for researchers, as it may be possible to develop compounds that can inhibit the activity of ERVFRD- 1 and prevent the replication of Env viruses.

ERVFRD-1 has also been shown to be involved in the development of various diseases, including cancer. Studies have shown that Env viruses are strongly associated with the development of cancer in various species, including humans. This suggests that ERVFRD-1 may be a valuable biomarker for cancer diagnosis and treatment.

In addition to its potential as a drug target and biomarker, ERVFRD-1 is also of interest to researchers because of its structural uniqueness. The four subunits of ERVFRD-1 are arranged in a specific order that is specific to this virus. This order is different from that of other Env viruses, which makes it possible to use ERVFRD-1 as a tool to study the biology of Env viruses.

Overall, ERVFRD-1 is a protein that is of great interest to researchers due to its structure, function, and potential as a drug target and biomarker. Further studies are needed to fully understand the role of ERVFRD-1 in the biology of Env viruses and its potential as a therapeutic agent.

Protein Name: Endogenous Retrovirus Group FRD Member 1, Envelope

Functions: This endogenous retroviral envelope protein has retained its original fusogenic properties and participates in trophoblast fusion and the formation of a syncytium during placenta morphogenesis. The interaction with MFSD2A is apparently important for this process (PubMed:18988732)

The "ERVFRD-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ERVFRD-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ERVK-6 | ERVK13-1 | ERVMER34-1 | ERVV-1 | ERVV-2 | ERVW-1 | ESAM | ESAM-AS1 | ESCO1 | ESCO2 | ESCRT-0 complex | ESCRT-I complex | ESCRT-II complex | ESCRT-III complex | ESD | ESF1 | ESM1 | ESPL1 | ESPN | ESPNL | ESPNP | ESR1 | ESR2 | ESRG | ESRP1 | ESRP2 | ESRRA | ESRRB | ESRRG | ESS2 | Estrogen receptor | Estrogen-related receptor (ERR) (nonspecifed subtype) | ESX1 | ESYT1 | ESYT2 | ESYT3 | ETAA1 | ETF1 | ETFA | ETFB | ETFBKMT | ETFDH | ETFRF1 | ETHE1 | ETNK1 | ETNK2 | ETNPPL | ETS1 | ETS2 | ETS2-AS1 | ETV1 | ETV2 | ETV3 | ETV3L | ETV4 | ETV5 | ETV6 | ETV7 | Eukaryotic translation initiation factor 2-alpha kinase | Eukaryotic translation initiation factor 2B | Eukaryotic translation initiation factor 3 (eIF-3) complex | Eukaryotic Translation Initiation Factor 4A (eIF-4A) | Eukaryotic Translation Initiation Factor 4E Binding Protein | EVA1A | EVA1A-AS | EVA1B | EVA1C | EVC | EVC2 | EVI2A | EVI2B | EVI5 | EVI5L | EVL | EVPL | EVPLL | EVX1 | EVX1-AS | EVX2 | EWSAT1 | EWSR1 | EXD1 | EXD2 | EXD3 | EXO1 | EXO5 | EXOC1 | EXOC1L | EXOC2 | EXOC3 | EXOC3-AS1 | EXOC3L1 | EXOC3L2 | EXOC3L4 | EXOC4 | EXOC5 | EXOC5P1 | EXOC6 | EXOC6B | EXOC7